Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

King Faisal Specialist Hospital & Research Center350 enrolled

Overview

Induction of mixed hemopoietic chimerism in patients using Fludarabine, Low Dose TBI, PBSC Infusion and post transplant in immunosuppression w/CSA \& Mycophenolate Mofetil

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

350

Conditions

Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Interventions

Mycophenolate MofetilDRUG

Induction of Mixed Hemopoietic Chimerism in Patients Using Mycophenolate Mofetil

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients receiving Fludarabine, Low Dose TBI, PBSC Infusion and post transplant in immunosuppression w/CSA \& Mycophenolate Mofetil. Exclusion Criteria: * Uncontrolled major medical illnesses

Locations (1)

KFSH&RC

Riyadh, Saudi Arabia

RECRUITING

Outcomes

Primary Outcomes

Efficacy

Time frame: 2001-2012

Central Contacts

Mahmoud AlJurf, MD

CONTACT

966-1-4647272 maljurf@kfshrc.edu.sa

Ed Colcol

CONTACT

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.